Welcome to our dedicated page for Claritev news (Ticker: CTEV), a resource for investors and traders seeking the latest updates and insights on Claritev stock.
Claritev Corporation reports developments for a healthcare technology, data and insights company serving the U.S. healthcare system. The company provides technology-enabled solutions built on claims expertise, advanced analytics and AI to support affordability, price transparency, payment integrity, network optimization and benefits design for payers, employers, patients, providers and third parties.
Recurring news includes quarterly results, guidance, investor-day strategy, conference participation, AI-focused leadership and workflow updates, product-roadmap themes and Claritev Cares community initiatives. Company updates often connect its analytics platform with healthcare cost management, revenue integrity and vertical-market expansion.
Claritev (NYSE: CTEV) announced that Marpai (OTCQX: MRAI) has expanded its relationship with Claritev beyond use of the PHCS Network for out-of-network access to include comprehensive pre- and post-payment integrity solutions across the claims lifecycle.
Marpai will adopt additional Claritev services such as Advanced Code Editing, Itemized Bill Review, DRG Validation, Data Mining, Coordination of Benefits, and Specialty Claim Reviews. According to Claritev, these capabilities are expected to help identify millions of dollars in potential savings opportunities for Marpai’s self-funded employer clients and improve claim payment accuracy. The expanded services are expected to be implemented within the next 90 days.
Claritev (NYSE: CTEV) reported Q2 2026 revenues of $257.5 million, up 6.6% from $241.6 million in Q2 2025. Net loss was $59.2 million, versus $62.6 million a year ago. Adjusted EBITDA rose 1.1% to $155.8 million, with a margin of 60.5% compared to 63.8%.
Net cash provided by operating activities increased to $92.7 million from $61.2 million, and Free Cash Flow improved to $54.6 million from $36.6 million. Claritev reported more than $70 million in bookings in the first half of 2026 toward a full‑year target of $100 million. The company raised 2026 guidance to $1.0–$1.02 billion in revenue, Adjusted EBITDA of $610–$620 million, and Free Cash Flow of $5–$15 million.
At June 30, 2026, total assets were $4.76 billion, long‑term debt was $4.59 billion plus $70 million drawn on the 2025 Revolving Credit Facility, and total shareholders’ deficit was $287.8 million.
Claritev Corporation (NYSE: CTEV) announced that its management team will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston. The appearance includes a fireside chat on Tuesday, August 11, 2026, at 10:00 a.m. ET, with a live webcast and audio archive available via Claritev’s investor relations website.
Claritev (NYSE: CTEV) reported that newly released 2025 data from the Centers for Medicare & Medicaid Services show it handled more federal Independent Dispute Resolution (IDR) claims than any other non-payer, making it the leading independent IDR administrator by volume.
According to Claritev, clients’ offers were selected in 20% of applicable 2025 determinations versus 12% industrywide, rising to 24% vs. 15% in Q4. The company priced more than 1 million claims using qualifying payment amount methodology, negotiated about 400,000 post-payment disputes, and managed roughly 270,000 federal IDR arbitrations, demonstrating national scale.
CMS data cited by Claritev show federal IDR filings reached 2.5 million disputes in 2025 versus 1.5 million in 2024, with total awards exceeding $15 billion, over triple 2024 levels. Claritev said it is investing in AI-native data, analytics, and workflow tools to help clients manage rising No Surprises Act dispute volumes and eligibility issues.
Claritev (NYSE: CTEV) and SAVVI Financial have launched Claritev Benefit Decision Support, a white-labeled solution that combines Claritev’s healthcare claims intelligence with SAVVI’s AI-powered financial Decision Intelligence platform. The tool aims to help employers offer personalized benefits guidance and enable employees to choose healthcare coverage and financial options aligned with their historical utilization and financial situation.
The solution integrates with leading HRIS, HCM, and benefits administration platforms, uses claims-informed, survey-less recommendations, and supports health-and-wealth optimization and claims-triggered notifications to improve engagement with medical and voluntary benefits, according to the companies.
Claritev (NYSE: CTEV) announced it will use CodeTogether's AITrax, an AI-specific measurement layer, to track adoption, cost, quality, and value of AI-assisted and agentic software development across its engineering organization. The move extends Claritev's use of CodeTogether's engineering intelligence platform, first deployed in 2022 across more than 1,000 technology associates and internally associated with a 59% increase in issue throughput and a 48% increase in active development time. AITrax will provide objective, IDE- and agent-level telemetry on AI usage, token consumption, agent sessions, and AI-generated code retention, aiming to help Claritev measure ROI by work model, forecast and manage AI spend, and identify training, governance, and workflow improvement opportunities.
Sun Life U.S. (TSX:SLF) is partnering with Claritev to enhance supplemental health benefits for self-funded employers. Claritev’s machine-learning technology continuously reviews medical claim data to identify when employees may be eligible for Sun Life critical illness, accident, and hospital indemnity benefits, enabling proactive outreach and faster benefit payments. The HIPAA-compliant solution is available for quoting now for policies effective on or after January 1, 2027, for self-funded employers offering Sun Life supplemental health coverage, excluding New York.
Claritev Corporation (NYSE: CTEV), a healthcare technology, data and insights company, announced it will release its second quarter fiscal 2026 financial results before market open on Friday, August 7, 2026. The company will host an earnings conference call at 8:00 a.m. Eastern Time the same day.
According to Claritev, a live webcast will be available via the Investor Relations section of its website at investors.claritev.com/events-and-presentations, with participants encouraged to join ten minutes early. An operator-assisted option is available by dialing 646-307-1963 and referencing Conference ID 7193168. The earnings press release and a supplemental slide deck will be posted on the Investor Relations site, and a replay of the call will be accessible afterward through the archived webcast.
Claritev (NYSE:CTEV) has been ranked a Leader in Everest Group's 2026 Pre-payment Integrity Solutions PEAK Matrix. The recognition reflects Claritev's connected payment integrity vision using responsible AI, automation, and clinical expertise.
In 2025, its payment integrity solutions generated about $1.8 billion in medical cost savings across more than 300 clients.
Claritev (NYSE:CTEV) announced that its management team will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference.
Chief Digital Officer Michael Kim will join a panel titled “The Data Before the AI: Building the Foundation for Scalable Healthcare Intelligence” on Wednesday, June 24, 2026, at 1:00pm ET.